BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6688679)

  • 21. Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone.
    Givens SS; Fuller LM; Hagemeister FB; Gehan EA
    Cancer; 1990 Jul; 66(1):69-74. PubMed ID: 2354411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
    Elconin JH; Roberts KB; Rizzieri DA; Vermont C; Clough RW; Kim C; Dodge RK; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1097-105. PubMed ID: 11072168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
    Fuller LM; Hagemeister FB; North LB; McLaughlin P; Velasquez WS; Cabanillas F
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):683-92. PubMed ID: 3280532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
    Roach M; Brophy N; Cox R; Varghese A; Hoppe RT
    J Clin Oncol; 1990 Apr; 8(4):623-9. PubMed ID: 2313331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
    Cramer P; Andrieu JM
    J Clin Oncol; 1985 Nov; 3(11):1495-502. PubMed ID: 3903063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
    Specht L; Nissen NI; Walbom-Jørgensen S
    Scand J Haematol; 1985 Aug; 35(2):166-73. PubMed ID: 3840275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90.
    Dieckmann K; Pötter R; Hofmann J; Heinzl H; Wagner W; Schellong G;
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):644-52. PubMed ID: 12788169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
    Hagemeister FB; Fuller LM; Sullivan JA; North L; Velasquez W; Conrad FG; McLaughlin P; Butler JJ; Shullenberger CC
    Radiology; 1981 Dec; 141(3):783-9. PubMed ID: 6895415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency.
    Leslie NT; Mauch PM; Hellman S
    Cancer; 1985 May; 55(9 Suppl):2072-8. PubMed ID: 3919921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Hagemeister FB; Purugganan R; Fuller L; McLaughlin P; Swan F; Romaguera J; Rodriguez M; Cabanillas F
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):36-43. PubMed ID: 8073308
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.
    Vecchi V; Pileri S; Burnelli R; Bontempi N; Comelli A; Testi AM; Carli M; Sotti G; Rosati D; Di Tullio MT
    Cancer; 1993 Sep; 72(6):2049-57. PubMed ID: 7689924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tomiŝiĉ R; Baaijens MH; Bortolus R; Lybeert ML; van der Maazen RW; Girinsky T; Demeestere G; Lugtenburg P; Lievens Y; de Jong D; Pinna A; Henry-Amar M;
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):19-30. PubMed ID: 17097834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hodgkin's disease with direct extension into pulmonary parenchyma from a mediastinal mass: a presentation requiring special therapeutic considerations.
    Wiernik PH; Slawson RG
    Cancer Treat Rep; 1982 Apr; 66(4):711-6. PubMed ID: 7074641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictive value of the early response to chemotherapy in high-risk stages II and III Hodgkin's disease.
    Levis A; Vitolo U; Ciocca Vasino MA; Cametti G; Urgesi A; Bertini M; Canta M; Monetti U; Bosio C; Jayme A
    Cancer; 1987 Oct; 60(8):1713-9. PubMed ID: 3651998
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
    Brusamolino E; Orlandi E; Morra E; Castelli G; Pagnucco G; Livraghi A; Astori C; Santagostino A; Lazzarino M; Bernasconi C
    Ann Oncol; 1994; 5 Suppl 2():53-7. PubMed ID: 7515648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A retrospective analysis of the treatment results in Hodgkin's disease in a radiotherapy clinic].
    Mjaaland I; Ganser D; Freitag EM; Bohndorf W
    Strahlenther Onkol; 1994 Sep; 170(9):516-23. PubMed ID: 7524173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Biti GP; Cimino G; Cartoni C; Magrini SM; Anselmo AP; Enrici RM; Bellesi GP; Bosi A; Papa G; Giannarelli D
    J Clin Oncol; 1992 Mar; 10(3):378-82. PubMed ID: 1740677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mediastinal masses in children with Hodgkin's disease. An analysis of the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania experience.
    Maity A; Goldwein JW; Lange B; D'Angio GJ
    Cancer; 1992 Jun; 69(11):2755-60. PubMed ID: 1373989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
    J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
    Edington H; Salwitz J; Longo DL; Roth JA; Pass H
    J Surg Oncol; 1986 Oct; 33(2):120-3. PubMed ID: 3762184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.